Trump administration adviser bats for use of anti-malaria drug
Shortpedia
Content Team
Image Credit: shortpedia
The debate regarding the use of an anti-malaria drug that hasn’t yet officially approved in COVID-19 treatment continues to make headlines. Trump administration adviser Peter Navarro, a trade adviser who is on the White House coronavirus task force, is keen on using the drug even though scientists have warned more testing is necessary before the drug can be announced safe and effective against the deadly COVID-19.
